142 related articles for article (PubMed ID: 30350642)
1. Potential Hepatitis B Vaccine Formulation Prepared by Uniform-Sized Lipid Hybrid PLA Microparticles with Adsorbed Hepatitis B Surface Antigen.
Liu Q; Chen X; Jia J; Lu T; Yang T; Wang L
Mol Pharm; 2018 Nov; 15(11):5227-5235. PubMed ID: 30350642
[TBL] [Abstract][Full Text] [Related]
2. Polycation-decorated PLA microspheres induce robust immune responses via commonly used parenteral administration routes.
Chen X; Wang L; Liu Q; Jia J; Liu Y; Zhang W; Ma G; Su Z
Int Immunopharmacol; 2014 Dec; 23(2):592-602. PubMed ID: 25466267
[TBL] [Abstract][Full Text] [Related]
3. The incorporation of cationic property and immunopotentiator in poly (lactic acid) microparticles promoted the immune response against chronic hepatitis B.
Lu T; Hu F; Yue H; Yang T; Ma G
J Control Release; 2020 May; 321():576-588. PubMed ID: 32112853
[TBL] [Abstract][Full Text] [Related]
4. Humoral and cell-mediated immune-responses after administration of a single-shot recombinant hepatitis B surface antigen vaccine formulated with cationic poly(l-lactide) microspheres.
Saini V; Jain V; Sudheesh MS; Dixit S; Gaur RL; Sahoo MK; Joseph SK; Verma SK; Jaganathan KS; Murthy PK; Kohli D
J Drug Target; 2010 Apr; 18(3):212-22. PubMed ID: 19883203
[TBL] [Abstract][Full Text] [Related]
5. Single dose HBsAg CS-γ-PGA nanogels induce potent protective immune responses against HBV infection.
Wang H; Han Q; Zhao H; Xu D; Zhang J
Eur J Pharm Biopharm; 2018 Mar; 124():82-88. PubMed ID: 29247691
[TBL] [Abstract][Full Text] [Related]
6. Biodegradable polylactide microspheres enhance specific immune response induced by Hepatitis B surface antigen.
Qiu S; Wei Q; Liang Z; Ma G; Wang L; An W; Ma X; Fang X; He P; Li H; Hu Z
Hum Vaccin Immunother; 2014; 10(8):2350-6. PubMed ID: 25424942
[TBL] [Abstract][Full Text] [Related]
7. Enhanced humoral and cell-mediated immune responses generated by cationic polymer-coated PLA microspheres with adsorbed HBsAg.
Chen X; Liu Y; Wang L; Liu Y; Zhang W; Fan B; Ma X; Yuan Q; Ma G; Su Z
Mol Pharm; 2014 Jun; 11(6):1772-84. PubMed ID: 24738485
[TBL] [Abstract][Full Text] [Related]
8. Molecular Evaluation of Oral Immunogenicity of Hepatitis B Antigen Delivered by Hydrogel Microparticles.
Chen XY; Butt AM; Mohd Amin MCI
Mol Pharm; 2019 Sep; 16(9):3853-3872. PubMed ID: 31398038
[TBL] [Abstract][Full Text] [Related]
9. Dimethyl-Dioctadecyl-Ammonium Bromide/Poly(lactic acid) Nanoadjuvant Enhances the Immunity and Cross-Protection of an NM2e-Based Universal Influenza Vaccine.
Gao Y; Han S; Lu F; Liu Q; Yang J; Wang W; Wang Y; Zhang J; Ju R; Shen X; Zhao Y; Wang H; Tan W; Wang L
ACS Nano; 2024 May; 18(20):12905-12916. PubMed ID: 38721835
[TBL] [Abstract][Full Text] [Related]
10. Cationic transfersomes based topical genetic vaccine against hepatitis B.
Mahor S; Rawat A; Dubey PK; Gupta PN; Khatri K; Goyal AK; Vyas SP
Int J Pharm; 2007 Aug; 340(1-2):13-9. PubMed ID: 17446015
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of solid lipid nanoparticles as carriers for delivery of hepatitis B surface antigen for vaccination using subcutaneous route.
Mishra H; Mishra D; Mishra PK; Nahar M; Dubey V; Jain NK
J Pharm Pharm Sci; 2010; 13(4):495-509. PubMed ID: 21486527
[TBL] [Abstract][Full Text] [Related]
12. Comparison of humoral and cell-mediated immune responses to cationic PLGA microspheres containing recombinant hepatitis B antigen.
Saini V; Jain V; Sudheesh MS; Jaganathan KS; Murthy PK; Kohli DV
Int J Pharm; 2011 Apr; 408(1-2):50-7. PubMed ID: 21291968
[TBL] [Abstract][Full Text] [Related]
13. Augmented humoral and cellular immune responses to hepatitis B DNA vaccine adsorbed onto cationic microparticles.
He X; Jiang L; Wang F; Xiao Z; Li J; Liu LS; Li D; Ren D; Jin X; Li K; He Y; Shi K; Guo Y; Zhang Y; Sun S
J Control Release; 2005 Oct; 107(2):357-72. PubMed ID: 16099068
[TBL] [Abstract][Full Text] [Related]
14. A novel dendritic-cell-targeting DNA vaccine for hepatitis B induces T cell and humoral immune responses and potentiates the antivirus activity in HBV transgenic mice.
Yu D; Liu H; Shi S; Dong L; Wang H; Wu N; Gao H; Cheng Z; Zheng Q; Cai J; Zou L; Zou Z
Immunol Lett; 2015 Dec; 168(2):293-9. PubMed ID: 26475398
[TBL] [Abstract][Full Text] [Related]
15. Systemic and mucosal immune response induced by transcutaneous immunization using Hepatitis B surface antigen-loaded modified liposomes.
Mishra D; Mishra PK; Dubey V; Nahar M; Dabadghao S; Jain NK
Eur J Pharm Sci; 2008 Apr; 33(4-5):424-33. PubMed ID: 18359615
[TBL] [Abstract][Full Text] [Related]
16. Posintro™-HBsAg, a modified ISCOM including HBsAg, induces strong cellular and humoral responses.
Schiött A; Larsson K; Manniche S; Kalliomäki S; Heydenreich AV; Dalsgaard K; Kirkby N
Int J Pharm; 2011 Jul; 414(1-2):312-20. PubMed ID: 21601626
[TBL] [Abstract][Full Text] [Related]
17. Improved storage stability and immunogenicity of hepatitis B vaccine after spray-freeze drying in presence of sugars.
Tonnis WF; Amorij JP; Vreeman MA; Frijlink HW; Kersten GF; Hinrichs WL
Eur J Pharm Sci; 2014 May; 55():36-45. PubMed ID: 24468629
[TBL] [Abstract][Full Text] [Related]
18. Co-delivery of polyinosinic:polycytidylic acid and flagellin by poly(lactic-
Dai X; He J; Zhang R; Wu G; Xiong F; Zhao B
Int J Nanomedicine; 2017; 12():6617-6632. PubMed ID: 28924346
[TBL] [Abstract][Full Text] [Related]
19. Robust Immune Responses Elicited by a Hybrid Adjuvant Based on β-Glucan Particles from Yeast for the Hepatitis B Vaccine.
Liu H; Meng Z; Wang H; Zhang S; Huang Z; Geng X; Guo R; Wu Z; Hong Z
ACS Appl Bio Mater; 2021 Apr; 4(4):3614-3622. PubMed ID: 35014447
[TBL] [Abstract][Full Text] [Related]
20. Intracellular signaling pathway in dendritic cells and antigen transport pathway in vivo mediated by an OVA@DDAB/PLGA nano-vaccine.
Han S; Ma W; Jiang D; Sutherlin L; Zhang J; Lu Y; Huo N; Chen Z; Engle JW; Wang Y; Xu X; Kang L; Cai W; Wang L
J Nanobiotechnology; 2021 Nov; 19(1):394. PubMed ID: 34838057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
